MANE

Veradermics, Incorporated

Healthcare · Biotechnology

121.20$ +2.9% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow MANE
Line item	2023	2024	2025
Operating Cash Flow	-0.07	-0.12	-2.04
Stock-Based Compensation	0.00	0.00	0.04
Change in Working Capital	0.00	0.00	-0.11
Capital Expenditures	0.00	0.00	0.00
Investing Cash Flow	–	–	-3.39
Net Borrowings	0.00	0.04	0.00
Financing Cash Flow	0.07	0.30	4.54
Change in Cash	0.00	0.18	-0.89
Free Cash Flow	-0.07	-0.12	-2.04

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.